MGMT and glioblastoma: In addition, for the frail elderly with Karnofsky performance score <70, Pérez-Larraya et al. [29] showed that temozolomide monotherapy was a well-tolerated regimen, and for the subgroup with MGMT-methylated GBM, survival outcomes were superior to historical control.